Package 67457-592-10

Brand: arixtra

Generic: fondaparinux sodium
NDC Package

Package Facts

Identity

Package NDC 67457-592-10
Digits Only 6745759210
Product NDC 67457-592
Description

10 SYRINGE, GLASS in 1 CARTON (67457-592-10) / .5 mL in 1 SYRINGE, GLASS (67457-592-00)

Marketing

Marketing Status
Marketed Since 2014-05-19
Brand arixtra
Generic fondaparinux sodium
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "8de301f7-88ad-41d7-9ec3-884cab56f943", "openfda": {"unii": ["X0Q6N9USOZ"], "rxcui": ["861356", "861358", "861360", "861362", "861363", "861364", "861365", "861366"], "spl_set_id": ["d3b30c68-cf45-4b46-8ba6-72090f7ba01a"], "manufacturer_name": ["Mylan Institutional LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 SYRINGE, GLASS in 1 CARTON (67457-592-10)  / .5 mL in 1 SYRINGE, GLASS (67457-592-00)", "package_ndc": "67457-592-10", "marketing_start_date": "20140519"}], "brand_name": "Arixtra", "product_id": "67457-592_8de301f7-88ad-41d7-9ec3-884cab56f943", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Factor Xa Inhibitor [EPC]", "Factor Xa Inhibitors [MoA]"], "product_ndc": "67457-592", "generic_name": "fondaparinux sodium", "labeler_name": "Mylan Institutional LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Arixtra", "active_ingredients": [{"name": "FONDAPARINUX SODIUM", "strength": "2.5 mg/.5mL"}], "application_number": "NDA021345", "marketing_category": "NDA", "marketing_start_date": "20140519", "listing_expiration_date": "20261231"}